Aysha Agarwal, MD
Critical Care Medicine (Internal Medicine) Physician in Phoenix, Arizona.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 6,646 in Critical Care Medicine (Internal Medicine) Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Source: CMS Medicare Part D Prescriber Public Use File, 2023
What the federal data shows
Aysha Agarwal, MD reported a CMS MIPS final score of 77/100 - below the 83.1 national average - and filed 350 Medicare Part D claims in 2023.
- 77/100
- MIPS score · -6 vs avg
- 350
- Part D claims, 2023
- 43%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Aysha Agarwal, MD's MIPS score vs every scored U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure
77 24th percentile higher than 24% of 477,587 scored providers
Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
Where Aysha Agarwal, MD sits
This provider among critical care medicine (internal medicine) physician peers
Across the 1,643 critical care medicine (internal medicine) physician providers who report both Medicare Part D prescribing and a MIPS quality score, Aysha Agarwal, MD writes more Part D claims than 32% of them and scores higher on MIPS quality than 25% - placing this provider in the lower-volume, lower-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.
Part D claim volume vs MIPS quality, by specialty percentile
Each dot is one critical care medicine (internal medicine) physician peer from a representative sample of 60; the gold marker is Aysha Agarwal, MD. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.
Aysha Agarwal, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 4 hospital affiliations - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Aysha Agarwal, MD?
Below national averagePrimary specialty
Medicare Part D claims
MIPS final score
Specialty distribution in Arizona
How Critical Care Medicine (Internal Medicine) Physician compares to other specialties among Arizona providers
Critical Care Medicine (Internal Medicine) Physician ranks #89 among Arizona's specialties (0.1% of in-state providers)
Each bar is a specialty's share of the Arizona provider total, by primary NUCC taxonomy. The highlighted bar is Critical Care Medicine (Internal Medicine) Physician; the long tail of smaller specialties is omitted for legibility.
Medicare quality performance, MIPS
Aysha Agarwal, MD's 2023 MIPS final score plotted against the Critical Care Medicine (Internal Medicine) Physician national average
- MIPS Final Score
- 77/100
- vs 83.1 national avg · 2023 performance year
MIPS final score (Critical Care Medicine (Internal Medicine) Physician) - 77/100 vs national avg 83.1
Quality benchmarks
- National MIPS avg 2023 reporting year
- Quality dim CMS Quality category
- Cost dim CMS Cost category
- Specialty volume Critical Care Medicine (Internal Medicine) Physician US NPIs
77/100 MIPS final score - 6.1 pts below the 83.1 national average
Quality, Cost, Promoting Interoperability, and Improvement Activities composite score for the 2023 performance year. Specialty: Critical Care Medicine (Internal Medicine) Physician. Quality dim: 59.7. Cost dim: 63.7.
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Aysha Agarwal, MD appears in the CMS NPPES registry as a Critical Care Medicine (Internal Medicine) Physician provider holding MD credentials at 9200 N CENTRAL AVE STE 3, Phoenix, AZ, 85020, with a listed phone of (602) 943-9494. NPI 1033564026 was issued on 04/27/2016.
Medicare Part D records for calendar year 2023 show 350 prescription claims written by this provider, covering 69 Medicare beneficiaries and totaling roughly $135K in drug spend, split 57% brand-name and 43% generic by claim count. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 77/100 for the 2023 performance year (Quality 59.7, Cost 63.7), compared with the national average of 83.1.
Critical Care Medicine (Internal Medicine) Physician is a mid-sized specialty nationwide, with 6,646 enrolled providers across 53 states and an average of 1,069 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline.
Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist, always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1033564026 |
|---|---|
| Specialty | Critical Care Medicine (Internal Medicine) Physician |
| Credentials | MD |
| Gender | Female |
| NPI Issued | 04/27/2016 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm Aysha Agarwal, MD's current license status, disciplinary history, and board certifications with the Arizona Medical Board in Arizona before relying on this page for a clinical or care decision.
How we sourced this profile
Profile fields combine the CMS NPPES monthly snapshot (provider directory, taxonomy, and address) with calendar-year 2023 Medicare Part D and MIPS public-use files when records are present. NPI 1033564026 is the unique 10-digit identifier CMS uses to link Agarwal across every Medicare, Medicaid, and HIPAA-covered transaction. Read full methodology →
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
Reporting: Group practice
Hospital and facility affiliations
Facilities where Aysha Agarwal, MD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
According to CMS billing records, Aysha Agarwal, MD is affiliated with 4 Medicare-billing facilities across 3 states.
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Aysha Agarwal, MD. Source: openpaymentsdata.cms.gov.
Total received
$29
Largest payer
ABIOMED
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
Brand vs generic prescribing mix · Brand-heavy
57% brand-name claims vs 43% generic, on 350 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 493
- Total Day Supply
- 13,742
- Brand vs Generic
- 57% brand / 43% generic
- Brand Drug Cost
- $125K
- Generic Drug Cost
- $10K
- Antibiotic Claims
- 15
Patient Demographics
- Average Patient Age
- 70.1 years
- Avg HCC Risk Score
- 1.79
- Gender Split
- 59% female / 41% male
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What Aysha Agarwal, MD prescribes most
Top Medicare Part D drugs by claim count, 2023
- Albuterol Sulfate …
Albuterol Sulfate Hfa
37 claims
- Prednisone
Prednisone
36 claims
- Anoro Ellipta
Anoro Ellipta
32 claims
- Fluticasone Propio…
Fluticasone Propionate
29 claims
- Trelegy Ellipta
Trelegy Ellipta
27 claims
- Advair Diskus
Advair Diskus
20 claims
- Stiolto Respimat
Stiolto Respimat
17 claims
- Montelukast Sodium 13
Montelukast Sodium
13 claims
| Drug | Claims |
|---|---|
| Albuterol Sulfate Hfa Albuterol Sulfate | 37 |
| Prednisone | 36 |
| Anoro Ellipta Umeclidinium Brm/Vilanterol Tr | 32 |
| Fluticasone Propionate | 29 |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 27 |
| Advair Diskus Fluticasone Propion/Salmeterol | 20 |
| Stiolto Respimat Tiotropium Br/Olodaterol Hcl | 17 |
| Montelukast Sodium | 13 |
| Symbicort Budesonide/Formoterol Fumarate | 13 |
| Spiriva Handihaler Tiotropium Bromide | 11 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Critical Care Medicine (Internal Medicine) Physician Overview
How Aysha Agarwal, MD fits within the Critical Care Medicine (Internal Medicine) Physician landscape nationally.
Aysha Agarwal, MD's 350 claims are below the specialty average of 1,069.
Nearby Critical Care Medicine (Internal Medicine) Physician Providers in Arizona
Other clinicians with the same primary specialty enrolled in Arizona, drawn from the same CMS NPPES roster as Agarwal.
Before you book an appointment
Use this federal record as your verification checklist, not as a recommendation.
- Confirm the NPI record is current in the official CMS registry, providers update their own NPPES details, and moves can lag. Verify this NPI
- Check the active license and any disciplinary history with the Arizona medical board, federal registration is not a license check. Credential verification guide
- Weigh a second option: compare this provider with a nearby Critical Care Medicine (Internal Medicine) Physician peer on Medicare volume and prescribing patterns. Compare providers
Medicare Part D and MIPS figures describe practice patterns in federal programs only, they are not quality ratings, and PlainDoctor does not rate, rank, or recommend providers.
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
Explore Arizona
Frequently Asked Questions
What is Aysha Agarwal, MD's specialty? ▼
How much does Aysha Agarwal, MD prescribe under Medicare Part D? ▼
What is Aysha Agarwal, MD's Medicare quality score? ▼
Where is Aysha Agarwal, MD located? ▼
What is Aysha Agarwal, MD's NPI number? ▼
Does Aysha Agarwal, MD prescribe more brand-name or generic drugs? ▼
How many Critical Care Medicine (Internal Medicine) Physician providers are there in the US? ▼
What drugs does Aysha Agarwal, MD prescribe most often? ▼
Does Aysha Agarwal, MD accept Medicare? ▼
How can I verify Aysha Agarwal, MD's credentials? ▼
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.
Published by
PlainDoctor Editorial
Independent public-data reference that compiles, verifies, and contextualizes official datasets. We do not accept compensation from entities we cover, and every dataset cites its originating public source.